Full Professor(heuristic)

Gene expression and cancer classification · Molecular Biology

Compare more Molecular Biology professors.

h-index19
i10-index28
Publications74
Citations6,929

Grants

24 total · 13 active

NIH #R35GM164148

Chemoenzymatic strategies for synthesizing glycans and glycoconjugates

Active
Amount
$600K–$700K
Period
2026-07-012031-04-30
PIs
1

Awarded at UNIVERSITY OF CALIFORNIA AT DAVIS

NIH #R01EY025009

Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care

Active
Amount
$700K–$800K
Period
2016-03-102030-05-31
PIs
2

Awarded at DUKE UNIVERSITY

NIH #R35GM127075

Study epigenetic inheritance during development, homeostasis and regeneration

Active
Amount
$300K–$400K
Period
2018-05-012029-04-30
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

24 total · 13 active

NIH #R35GM164148

Chemoenzymatic strategies for synthesizing glycans and glycoconjugates

Active
Amount
$600K–$700K
Period
2026-07-012031-04-30
PIs
1

Awarded at UNIVERSITY OF CALIFORNIA AT DAVIS

NIH #R01EY025009

Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care

Active
Amount
$700K–$800K
Period
2016-03-102030-05-31
PIs
2

Awarded at DUKE UNIVERSITY

NIH #R35GM127075

Study epigenetic inheritance during development, homeostasis and regeneration

Active
Amount
$300K–$400K
Period
2018-05-012029-04-30
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

NSF #2238129

CAREER: Programmable Negative Water Adsorption of Bioinspired Hygroscopic Materials

Active
Amount
$500K–$600K
Period
2023-08-012028-07-31
PIs
1

Awarded at Research Foundation CUNY - Advanced Science Research Center

NIH #R01CA270240

Proteostasis Reprogramming in Mutant KRAS-Driven Cancers

Active
Amount
$500K–$600K
Period
2022-12-012028-05-31
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R21CA303374

Therapeutic Targeting of Upregulated BAP1 in Human Hepatocellular Carcinoma

Active
Amount
$400K–$500K
Period
2026-05-012028-04-30
PIs
1

Awarded at UNIVERSITY OF HAWAII AT MANOA

NIH #R21TR006182

AAV9fyhr gene replacement therapy for PDHA1 deficiency in the E75A mouse model

Active
Amount
$400K–$500K
Period
2026-05-012028-04-30
PIs
1

Awarded at UT SOUTHWESTERN MEDICAL CENTER

NIH #K99AI196240

Characterizing autoreactive B cells and their roles in the pathogenesis of SLE using immune organoids

Active
Amount
$100K–$200K
Period
2026-04-012028-03-31
PIs
1

Awarded at STANFORD UNIVERSITY

NIH #R21NS146806

CMT4A and CMT2K Gene Replacement Therapy with AAV9/GDAP1 in Rats

Active
Amount
$200K–$300K
Period
2026-02-152028-01-31
PIs
1

Awarded at UT SOUTHWESTERN MEDICAL CENTER

NIH #R41DA064241

Targeting novel translation mechanism to treat NFOO-induced hypoxia-related brain injuries

Active
Amount
$300K–$400K
Period
2026-07-012027-06-30
PIs
1

Awarded at TRANSCHROMIX, LLC.

NIH #R01AG077529

A Life Course Approach to Understanding Population Heterogeneity in Alzheimer’s Disease and Related Dementias and Health Care Utilization

Active
Amount
$600K–$700K
Period
2022-07-012027-05-31
PIs
1

Awarded at YALE UNIVERSITY

NIH #UG3CA290375

Discovery of novel natural TEAD inhibitors for the chemoprevention of liver tumors

Active
Amount
$100K–$200K
Period
2024-05-142027-04-30
PIs
3

Awarded at UNIVERSITY OF HAWAII AT HILO

NSF #2144328

CAREER: Understanding the Size Effects on Spin-mediated Thermal Transport in Nanostructured Quantum Magnets

Active
Amount
$500K–$600K
Period
2022-03-012027-02-28
PIs
1

Awarded at University of California-Riverside

NSF #2304959

Collaborative Research: Water-responsive, Shape-shifting Supramolecular Protein Assemblies

Amount
$100K–$200K
Period
2023-08-012026-07-31
PIs
1

Awarded at Research Foundation CUNY - Advanced Science Research Center

NSF #1845444

CAREER: A Sequential Learning Framework with Applications to Learning from Crowds

Amount
$400K–$500K
Period
2019-03-012026-02-28
PIs
1

Awarded at New York University

NSF #1846663

CAREER: Model-Free Input Screening and Sensitivity Analysis in Simulation Metamodeling

Amount
$500K–$600K
Period
2019-09-012025-08-31
PIs
1

Awarded at Virginia Polytechnic Institute and State University

NSF #2344305

NSF Convergence Accelerator Track M: Water-responsive Materials for Evaporation Energy Harvesting

Amount
$600K–$700K
Period
2024-01-152025-06-30
PIs
5

Awarded at Research Foundation CUNY - Advanced Science Research Center

NSF #1849300

S&AS: INT: Traffic Deconfliction for Smart and Autonomous Unmanned Aircraft Systems in Congested Environments

Amount
$800K–$900K
Period
2019-02-152022-09-30
PIs
2

Awarded at Virginia Polytechnic Institute and State University

NSF #1149257

CAREER: Bridging Game Theory, Economics and Computer Science: Equilibria, Fixed Points, and Beyond

Amount
$400K–$500K
Period
2012-07-012017-06-30
PIs
1

Awarded at Columbia University

NSF #1300449

SusChEM: Chemoenzymatic Methods for Efficient Synthesis of Glycolipids

Amount
$100K–$200K
Period
2013-09-152015-08-31
PIs
1

Awarded at University of California-Davis

NSF #1012511

Chemoenzymatic methods for automated carbohydrate synthesis

Amount
$300K–$400K
Period
2010-09-012013-08-31
PIs
1

Awarded at University of California-Davis

NSF #0643726

PECASE: The Science Underpinning Mechanical Self-Assembly

Amount
$400K–$500K
Period
2007-03-012013-02-28
PIs
1

Awarded at Columbia University

NSF #0548235

CAREER: Harnessing enzymes in novel synthesis of complex carbohydrates

Amount
$600K–$700K
Period
2006-01-012010-12-31
PIs
1

Awarded at University of California-Davis

NSF #0407743

Measurement of Mechanical Properties of Small Material Structures by Nanoindentation

Amount
$200K–$300K
Period
2004-07-012008-06-30
PIs
1

Awarded at Columbia University

Recent Public Signals

  1. New NIH award: Chemoenzymatic strategies for synthesizing glycans and glycoconjugates2026-07-01
  2. New NIH award: Targeting novel translation mechanism to treat NFOO-induced hypoxia-related brain injuries2026-07-01
  3. New NIH award: Therapeutic Targeting of Upregulated BAP1 in Human Hepatocellular Carcinoma2026-05-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-08-30

Data may not be current

Find elsewhere

ORCID: 0000-0001-7094-6748

Professor Insights

Career Trajectory